entertainment -WSS

entertainment

author：entertainment 2025-09-29 22:46:37 - browse：428

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Medicare inequities exacerbate Puerto Rico’s health disparities

WSS

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Life science postdocs should get big pay hike, NIH panel says

Medicare inequities exacerbate Puerto Rico’s health disparities

Gene therapy denied for Afghan refugee whose father aided U.S.

Profiling embryos to choose those with higher IQs is almost a reality

Antivenom research: Lessons from HIV applied in search for universal antidote

leisure time

entertainment

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Wildfire smoke exposes gaps in outdoor worker protections

Medicare Advantage overpayments discussion gets experts fired up

Guidelines to prevent youth baseball injuries need more muscle

In utero gene editing: an explainer

Heart attack and stroke risk calculators need revising

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Walensky prepares to leave CDC — and Congress — behind

Male doctors called my cancer incurable. A female doctor showed it wasn't

knowledge

Obesity drugs seen as possible treatment for liver disease MASH

Alabama IVF ruling threatens families facing fatal genetic disease

Does Paxlovid work in people vaccinated against Covid

Hospital chaplains balance Covid safety with patients’ spiritual needs

In shift, Texas to cover initial consult for Afghan baby's gene therapy

At JPM 2024, hospital systems pitch financial strength to investors

focus

Wikipedia

knowledge

knowledge